Häntzschel H, Otto W, Arnold S, Seidel W, Krüger W, Winiecki P, Bird H A, Dixon J S, Astbury G, Wright V
Division of Rheumatology, Medical Policlinical Institute, Bereich Medizin Karl-Marx-University, Leipzig, GDR.
Clin Rheumatol. 1988 Jun;7(2):181-7. doi: 10.1007/BF02204452.
Pulse prednisolone hemisuccinate therapy (500 mg given intravenously on three occasions over two weeks) has been combined with either intramuscular sodium aurothiomalate or azathioprine in an assessment of 30 patients with rheumatoid arthritis. Significant improvement in a variety of clinical and biochemical assessments was seen in both groups. Both treatments were well tolerated by the patients and prednisolone appeared to accelerate the response to sodium aurothiomalate and azathioprine but there was no great evidence that it enhanced it.
在一项对30例类风湿性关节炎患者的评估中,采用了脉冲式琥珀酸半氢化泼尼松疗法(两周内分三次静脉注射500毫克),并联合肌肉注射金硫代苹果酸钠或硫唑嘌呤。两组患者在各种临床和生化评估中均有显著改善。两种治疗方法患者耐受性良好,泼尼松似乎加快了对金硫代苹果酸钠和硫唑嘌呤的反应,但没有充分证据表明它增强了这种反应。